DK255786A - Quinazolinderivater eller farmaceutisk acceptable salte eller estere deraf, deres fremstilling og anvendelse som farmaceutika - Google Patents
Quinazolinderivater eller farmaceutisk acceptable salte eller estere deraf, deres fremstilling og anvendelse som farmaceutika Download PDFInfo
- Publication number
- DK255786A DK255786A DK255786A DK255786A DK255786A DK 255786 A DK255786 A DK 255786A DK 255786 A DK255786 A DK 255786A DK 255786 A DK255786 A DK 255786A DK 255786 A DK255786 A DK 255786A
- Authority
- DK
- Denmark
- Prior art keywords
- group
- heteroatom
- quinazoline derivatives
- pharmaceuticals
- esters
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical class N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- 125000005842 heteroatom Chemical group 0.000 abstract 5
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 3
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- 229930195734 saturated hydrocarbon Natural products 0.000 abstract 2
- 229930195735 unsaturated hydrocarbon Natural products 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000002837 carbocyclic group Chemical group 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 125000002294 quinazolinyl group Chemical class N1=C(N=CC2=CC=CC=C12)* 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB858513754A GB8513754D0 (en) | 1985-05-31 | 1985-05-31 | Anti-cancer quinazoline derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK255786D0 DK255786D0 (da) | 1986-05-30 |
| DK255786A true DK255786A (da) | 1986-12-01 |
Family
ID=10579966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK255786A DK255786A (da) | 1985-05-31 | 1986-05-30 | Quinazolinderivater eller farmaceutisk acceptable salte eller estere deraf, deres fremstilling og anvendelse som farmaceutika |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5236927A (da) |
| EP (1) | EP0204529B1 (da) |
| JP (1) | JPS61282368A (da) |
| AT (1) | ATE87621T1 (da) |
| AU (1) | AU592271B2 (da) |
| DE (1) | DE3688150T2 (da) |
| DK (1) | DK255786A (da) |
| ES (1) | ES8800911A1 (da) |
| FI (1) | FI862303A7 (da) |
| GB (2) | GB8513754D0 (da) |
| GR (1) | GR861418B (da) |
| HU (1) | HUT45512A (da) |
| IL (1) | IL78910A0 (da) |
| NO (1) | NO862170L (da) |
| NZ (1) | NZ216363A (da) |
| PT (1) | PT82682B (da) |
| ZA (1) | ZA864051B (da) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8607683D0 (en) * | 1986-03-27 | 1986-04-30 | Ici Plc | Anti-tumor agents |
| GB8707053D0 (en) * | 1987-03-25 | 1987-04-29 | Ici Plc | Anti-tumour agents |
| US4857530A (en) * | 1987-11-03 | 1989-08-15 | Warner-Lambert Company | Substituted quinazolinones as anticancer agents |
| GB8809978D0 (en) * | 1988-04-27 | 1988-06-02 | Ici Plc | Anti-tumour agents |
| EP0365763A1 (en) * | 1988-09-30 | 1990-05-02 | Agouron Pharmaceuticals, Inc. | Antiproliferative cyclic compounds |
| US5286726A (en) * | 1990-04-12 | 1994-02-15 | The Regents Of The University Of Michigan | Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases |
| US6762188B1 (en) | 1990-06-19 | 2004-07-13 | Smithkline Beecham Corporation | Pharmaceutically active benzoquinazoline compounds |
| GB9013615D0 (en) | 1990-06-19 | 1990-08-08 | Wellcome Found | Pharmaceutical compounds |
| GB9105771D0 (en) * | 1991-03-19 | 1991-05-01 | Cancer Res Inst Royal | Anti-cancer compounds |
| GB9205320D0 (en) * | 1992-03-11 | 1992-04-22 | Ici Plc | Anti-tumour compounds |
| GB9205907D0 (en) * | 1992-03-18 | 1992-04-29 | Cancer Res Inst Royal | Anti-cancer compounds |
| US5430148A (en) * | 1992-03-31 | 1995-07-04 | Agouron Pharmaceuticals, Inc. | Antiproliferative quinazolines |
| GB9223352D0 (en) * | 1992-11-06 | 1992-12-23 | Ici Plc | Tricyclic compounds |
| US7262058B2 (en) * | 2001-03-09 | 2007-08-28 | Nonda Katopodis | Method for determining lipid associated sialoprotein in body fluids |
| RU2005115106A (ru) * | 2002-10-18 | 2005-10-10 | Конинклейке Филипс Электроникс Н.В. (Nl) | Способ, система, устройство, сигнал и программный продукт для защиты метаданных в tv-anytime |
| US20060052345A1 (en) * | 2002-11-04 | 2006-03-09 | Nps Pharmaceuticals, Inc. | Quinazolinone compounds as calcilytics |
| JP2009501235A (ja) * | 2005-07-15 | 2009-01-15 | シェーリング コーポレイション | 癌処置において有用なキナゾリン誘導体 |
| MX2008000744A (es) * | 2005-07-15 | 2008-03-10 | Schering Corp | Derivados de quinazolina utiles en el tratamiento del cancer. |
| CA2663436A1 (en) | 2006-10-04 | 2008-04-10 | Pfizer Products Inc. | Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists |
| EP2220050A2 (en) | 2007-10-26 | 2010-08-25 | The Regents Of The University Of California | Diarylhydantoin compounds as androgen receptor modulators |
| ES3031438T3 (en) | 2009-06-25 | 2025-07-08 | Alkermes Pharma Ireland Ltd | Heterocyclic compounds for the treatment of neurological and psychological disorders |
| AU2010339689B2 (en) * | 2010-01-07 | 2015-02-19 | Alkermes Pharma Ireland Limited | Quaternary ammonium salt prodrugs |
| WO2011163594A2 (en) | 2010-06-24 | 2011-12-29 | Alkermes, Inc. | Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives |
| US9034867B2 (en) | 2011-03-18 | 2015-05-19 | Alkermes Pharma Ireland Limited | Pharmaceutical compositions comprising sorbitan esters |
| JP6219918B2 (ja) | 2012-03-19 | 2017-10-25 | アルカームス ファーマ アイルランド リミテッド | グリセロールエステルを含む医薬組成物 |
| WO2013142198A1 (en) | 2012-03-19 | 2013-09-26 | Alkermes Pharma Ireland Limited | Pharmaaceutical compositions comprising fatty acid esters |
| WO2013142205A1 (en) | 2012-03-19 | 2013-09-26 | Alkermes Pharma Ireland Limited | Pharmaceutical compositions comprising benzyl alcohol |
| EP3718536A1 (en) | 2012-09-19 | 2020-10-07 | Alkermes Pharma Ireland Limited | Pharmaceutical compositions having improved storage stability |
| EP3119399A4 (en) | 2014-03-20 | 2017-09-27 | Alkermes Pharma Ireland Limited | Aripiprazole formulations having increased injection speeds |
| CA3092335A1 (en) | 2018-03-05 | 2019-09-12 | Alkermes Pharma Ireland Limited | Aripiprazole dosing strategy |
| WO2024028999A1 (ja) * | 2022-08-03 | 2024-02-08 | Ils株式会社 | N-[4-メチルアミノベンゾイル]-l-グルタミン酸ジエチルエステルの製造方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1021196A (en) * | 1964-02-20 | 1966-03-02 | Parke Davis & Co | Novel amino acids and means for producing the same |
| US3471498A (en) * | 1967-08-11 | 1969-10-07 | Parke Davis & Co | Certain n-p-((2,4-diamino-6-quinazolinyl)-methyl)benzoylamino acids |
| EP0031237B1 (en) * | 1979-12-19 | 1984-10-17 | National Research Development Corporation | Quinazoline derivatives, processes for their preparation, compositions containing them and their use as anti-cancer agents |
| GB8607683D0 (en) * | 1986-03-27 | 1986-04-30 | Ici Plc | Anti-tumor agents |
-
1985
- 1985-05-31 GB GB858513754A patent/GB8513754D0/en active Pending
-
1986
- 1986-05-26 IL IL78910A patent/IL78910A0/xx unknown
- 1986-05-30 DE DE8686304148T patent/DE3688150T2/de not_active Expired - Fee Related
- 1986-05-30 GR GR861418A patent/GR861418B/el unknown
- 1986-05-30 HU HU862288A patent/HUT45512A/hu unknown
- 1986-05-30 GB GB08613184A patent/GB2175903B/en not_active Expired
- 1986-05-30 ZA ZA864051A patent/ZA864051B/xx unknown
- 1986-05-30 AT AT86304148T patent/ATE87621T1/de not_active IP Right Cessation
- 1986-05-30 FI FI862303A patent/FI862303A7/fi not_active Application Discontinuation
- 1986-05-30 NO NO862170A patent/NO862170L/no unknown
- 1986-05-30 NZ NZ216363A patent/NZ216363A/xx unknown
- 1986-05-30 ES ES555548A patent/ES8800911A1/es not_active Expired
- 1986-05-30 AU AU58220/86A patent/AU592271B2/en not_active Ceased
- 1986-05-30 JP JP61125587A patent/JPS61282368A/ja active Pending
- 1986-05-30 EP EP86304148A patent/EP0204529B1/en not_active Expired - Lifetime
- 1986-05-30 DK DK255786A patent/DK255786A/da not_active Application Discontinuation
- 1986-05-30 PT PT82682A patent/PT82682B/pt not_active IP Right Cessation
-
1990
- 1990-12-12 US US07/625,695 patent/US5236927A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE3688150T2 (de) | 1993-07-29 |
| GR861418B (en) | 1986-09-26 |
| EP0204529A2 (en) | 1986-12-10 |
| GB2175903B (en) | 1988-10-12 |
| FI862303A7 (fi) | 1986-12-01 |
| JPS61282368A (ja) | 1986-12-12 |
| AU5822086A (en) | 1986-12-04 |
| NZ216363A (en) | 1989-07-27 |
| US5236927A (en) | 1993-08-17 |
| GB8613184D0 (en) | 1986-07-02 |
| GB8513754D0 (en) | 1985-07-03 |
| DK255786D0 (da) | 1986-05-30 |
| HUT45512A (en) | 1988-07-28 |
| FI862303A0 (fi) | 1986-05-30 |
| DE3688150D1 (de) | 1993-05-06 |
| GB2175903A (en) | 1986-12-10 |
| EP0204529B1 (en) | 1993-03-31 |
| ES8800911A1 (es) | 1987-12-01 |
| NO862170L (no) | 1986-12-01 |
| IL78910A0 (en) | 1986-09-30 |
| ATE87621T1 (de) | 1993-04-15 |
| ZA864051B (en) | 1987-01-28 |
| PT82682A (en) | 1986-06-01 |
| EP0204529A3 (en) | 1987-11-19 |
| PT82682B (pt) | 1988-03-03 |
| AU592271B2 (en) | 1990-01-04 |
| ES555548A0 (es) | 1987-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK255786D0 (da) | Quinazolinderivater eller farmaceutisk acceptable salte eller estere deraf, deres fremstilling og anvendelse som farmaceutika | |
| ES8300716A1 (es) | Procedimiento para preparar derivados de 2-amino-4-hidroxi- quinazolina | |
| PT91121A (pt) | Processo para a preparacao de derivados da quinolina e de composicoes farmaceuticas que os contem | |
| MX171822B (es) | Proceso quimico | |
| ES8704938A1 (es) | Procedimiento para preparar nuevos derivados aminicos heteroaromaticos | |
| DK114783A (da) | Hidtil ukendte forbindelser, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler | |
| DK37189D0 (da) | Substituerede quinoliner og cinnoliner, fremgangsmaader til deres fremstilling samt deres anvendelse | |
| PT82854B (pt) | Processo para a preparacao de derivados do acido piridono-carboxilico | |
| FR2526659B1 (fr) | Medicaments immunomodulants a base de derives de l'acide phenylacetique | |
| AR241422A1 (es) | Procedimiento para la preparacion de derivados de difenil(metil-etil-0 etenil) piperidinas. | |
| DE3665711D1 (de) | Novel guanidinomethylbenzoic acid derivatives | |
| DK529585A (da) | N-(6-methoxy-5-(perflouralkyl)-1-naphtholyl)-n-methylglyciner og deres thionaphthoyl analoge, deres fremstilling og anvendelse som laegemidler | |
| PT89757A (pt) | Processo para a preparacao de novos derivados da xantina e de composicoes farmaceuticas que os contem, uteis no tratamento da ulcera peptica | |
| ES550971A0 (es) | Un procedimiento para la preparacion de nuevos derivados de esteres fosforicos. | |
| PT83975B (pt) | Processo para a preparacao de derivados de 5-aminoalquil-beta-carbolinas e de composicoes farmaceuticas que os contem | |
| DK614989D0 (da) | Indolderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem | |
| ATE87307T1 (de) | Isoindolinderivate und verfahren zu ihrer herstellung. | |
| ES2003758A6 (es) | Procedimiento para preparar nuevos derivados de acidos fenilaceticos | |
| ATE144900T1 (de) | Verwendung von xanthinderivaten gegen magengeschwüre | |
| ES2045335T3 (es) | Un procedimiento para la preparacion de nuevas s-difluorometilhomocisteinas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |